Gynecologic Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Gynecologic
| Protocol | NRG CC008 |
|---|---|
| Cancer Type: | Ovarian Cancer Among BRCA1 Carriers |
| Fast Facts |
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
| Protocol | NRG GY019 |
|---|---|
| Cancer Type: | Carcinoma of the Ovary or Peritoneum |
| Fast Facts |
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
| Protocol | EAY191 - N4 |
|---|---|
| Cancer Type: | Rare Cancer |
A RANDOMIZED TRIAL OF SELUMETINIB AND OLAPARIB
OR SELUMETINIB ALONE IN PATIENTS WITH RECURRENT OR
PERSISTENT RAS PATHWAY MUTANT OVARIAN AND ENDOMETRIAL
CANCERS
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG GY026 |
|---|---|
| Cancer Type: | Endometrial serous carcinoma or carcinosarcoma |
| Fast Facts |
A Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) or pertuzumab trastuzumab and hyaluronidase-zzfx (PHESGO) in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG GY024 |
|---|---|
| Cancer Type: | Vulvar Cancer |
| Fast Facts |
Groningen International Study on Sentinel Nodes in Vulvar Cancer III (GROINSS-V III), a prospective phase II treatment trial
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
